A new grant could provide NIH researchers with the necessary funding for key advancements in DNA sequencing.
Researchers: New Pfizer drug failed in key cancer trial
The company had hoped to show that combining Torisel with Avastin would be even more effective in extending progression-free survival than Avastin combined with interferon-alfa-2a.